The Food and Drug Administration today reported 55 injuries and one death involving an infusion pump and vital signs monitoring system. Becton Dickinson CareFusion 303 Inc. recalled the Alaris Infusion Pump System and Modules in February due to software and other errors that can delay, speed or interrupt the infusion of medications and other fluids to patients. According to FDA, consumers should follow the manufacturer’s recommended actions to help mitigate the potential risk of errors until the software issues have been remediated. Health care providers may report associated adverse reactions or quality problems to FDA’s MedWatch reporting program.

Related News Articles

Headline
A new special issue of Health Services Research focuses on how health care organizations can use implementation science — the study of strategies that…
Headline
The Centers for Disease Control and Prevention last week released the procedure for laboratory personnel using its generic real-time PCR test to diagnose…
Headline
The Centers for Disease Control and Prevention today reported over 1,300 monkeypox cases globally, including 45 in the United States. While no deaths have been…
Headline
The Food and Drug Administration yesterday released an update on Medtronic’s recall of 1,614 devices used to pump blood from the heart to the rest of the…
Headline
The House yesterday voted 392-28 to pass legislation (H.R. 7667) that would reauthorize Food and Drug Administration user fee programs, which provide funding…
Headline
The AHA today joined the U.S. Chamber of Commerce and American Medical Association in urging the 6th Circuit Court of Appeals to overturn a district court…